Document is current
Any future updates will be listed below
-
Authors
Fishman, M.
Dutcher, J. P. http://orcid.org/0000-0002-2267-9187
Clark, J. I.
Alva, A.
Miletello, G. P.
Curti, B.
Agarwal, Neeraj
Hauke, R.
Mahoney, K. M.
Moon, H.
Treisman, J.
Tykodi, S. S.
Daniels, G.
Morse, M. A.
Wong, M. K. K.
Kaufman, H.
Gregory, N.
McDermott, D. F.
- License Information
-
More Information
Article History
Received: 5 December 2018
Accepted: 14 March 2019
First Online: 27 March 2019
Ethics approval and consent to participate
: This registry study was approved by the institutional review boards of the sites enrolling subjects, and all patients provided written, informed consent.
: Not applicable.
: MF has received research funding from Eisai, Pfizer, Prometheus, Merck, Tracon, Eisai, Exelixis; JPD is a consultant for Prometheus Laboratories, and member of data safety and monitoring committees for BMS, Merck, Tracon, Amgen, Iovance, Eisai, PrECOG, and medical oncology co-chair of the NCI Renal Cancer Task Force; JIC is on speakers bureau for BMS, Merck; AA participates in advisory boards for Merck, Astra Zeneca; AA receives research funding from Clovis, Merck, BMS, Astra Zeneca, Bayer, Progenics, Janssen, Genentech, Guardant Health, Esanik, Ionnis, Prometheus; GPM declares no conflicts; BC is consultant for Eisai, Alligator, Iovance; Travel support from MedImmune Alligator; Research support from BMS, MedImmune, Prometheus, Viralytics, Galectin Therapeutics; NA is consultant to Pfizer, Novartis, Merck, Genentech, Eisai, Exelixis, Clovis, EMD Serono, BMS, Astra Zeneca, Astellas, Ely Lilly, Bayer, Pharmacyclics; RH declares no conflicts; KMM declares no conflicts; HM declares no conflicts; JT declares no conflicts; SST receives research support from Peloton, Merck, Nektar, Calithera, Jounce, Pfizer, Genetech, Prometheus, BMS; serves on advisory board for Calithera, Prometheus, BMS.; GD declares no conflicts; MAM receives research support from Merck and BMS, and honoraria from Merck; HK is an employee of Replimune, Inc.; MKKW declares no conflicts; NG is an employee of Prometheus Laboratories; DMcD is a consultant for BMS, Pfizer, Merck, Novartis, Eisai, Exelixis, Array BioPharm, Genentech BioOncology, Jounce and receives research funding from Prometheus Laboratories and BMS; JIC, BC, GD, MAM, MKKW, HK, DFM, JPD are unpaid members of the PROCLAIM Steering Committee.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
